As data analytics stocks’ Q4 earnings season wraps, let's dig into this quarter's best and worst performers, including Alteryx (NYSE:AYX) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.
The 5 data analytics stocks we track reported a weak Q4; on average, revenues beat analyst consensus estimates by 3.05%, while on average next quarter revenue guidance was 0.72% under consensus. There has been a stampede out of high valuation technology stocks as raising interest rates encourage investors to value profits over growth again and data analytics stocks have not been spared, with share prices down 15.3% since the previous earnings results, on average.
Best Q4: Alteryx (NYSE:AYX)
Initially created as a way to organise census data for the government, Alteryx (NYSE:AYX) provides software that helps companies automate and analyse their internal data processes.
Alteryx reported revenues of $301.1 million, up 73.2% year on year, beating analyst expectations by 7.79%. It was a decent quarter for the company, with exceptional revenue growth but underwhelming guidance for the next year.
"Alteryx delivered an excellent fourth quarter with annual recurring revenue (ARR) growth of 31% year-over-year, driven by continued success with large enterprises. We closed the year with strong momentum and improving operating profitability," said Mark Anderson, CEO of Alteryx, Inc.
Alteryx pulled off the strongest analyst estimates beat, fastest revenue growth, and highest full year guidance raise of the whole group. The company added 18 customers to a total of 8,358. The stock is down 5.82% since the results and currently trades at $56.59.
Is now the time to buy Alteryx? Access our full analysis of the earnings results here, it's free.
Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.
Amplitude reported revenues of $65.3 million, up 32% year on year, beating analyst expectations by 2.63%. It was a weak quarter for the company, with a full year guidance missing analysts' expectations and a decline in the net retention rate.
The stock is down 31.7% since the results and currently trades at $11.44.
Is now the time to buy Amplitude? Access our full analysis of the earnings results here, it's free.
Slowest Q4: Health Catalyst (NASDAQ:HCAT)
Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.
Health Catalyst reported revenues of $69.2 million, up 6.87% year on year, beating analyst expectations by 1.32%. It was a weak quarter for the company, with a full year guidance missing analysts' expectations and a decline in gross margin.
Health Catalyst had the slowest revenue growth in the group. The stock is down 19.3% since the results and currently trades at $11.28.
Read our full analysis of Health Catalyst's results here.
Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.
Domo reported revenues of $79.6 million, up 13.8% year on year, beating analyst expectations by 2.77%. It was a weak quarter for the company, with underwhelming guidance for the next year.
The stock is down 25.8% since the results and currently trades at $12.22.
Read our full, actionable report on Domo here, it's free.
Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.
Palantir reported revenues of $508.6 million, up 17.5% year on year, in line with analyst expectations. It was a weak quarter for the company, with a full year guidance missing analysts' expectations and underwhelming revenue guidance for the next quarter.
Palantir had the weakest performance against analyst estimates and weakest full year guidance update among the peers. The stock is up 6.12% since the results and currently trades at $8.06.
Read our full, actionable report on Palantir here, it's free.
The author has no position in any of the stocks mentioned